MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 137 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $32,000 | -65.6% | 25,940 | -13.8% | 0.01% | -67.9% |
| Q1 2017 | $93,000 | -31.1% | 30,090 | -9.3% | 0.03% | -34.9% |
| Q4 2016 | $135,000 | -56.3% | 33,190 | -31.7% | 0.04% | -55.7% |
| Q3 2016 | $309,000 | +27.7% | 48,601 | +8.3% | 0.10% | +24.4% |
| Q2 2016 | $242,000 | -35.5% | 44,861 | 0.0% | 0.08% | -38.6% |
| Q1 2016 | $375,000 | +124.6% | 44,861 | +112.7% | 0.13% | +115.3% |
| Q4 2015 | $167,000 | +10.6% | 21,090 | +19.2% | 0.06% | -3.3% |
| Q3 2015 | $151,000 | -28.4% | 17,700 | +3.5% | 0.06% | -17.6% |
| Q2 2015 | $211,000 | -9.4% | 17,100 | -12.8% | 0.07% | -17.8% |
| Q1 2015 | $233,000 | -0.4% | 19,600 | -5.3% | 0.09% | -3.2% |
| Q4 2014 | $234,000 | – | 20,700 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |